Medullary thyroid cancer: Which Medications Are Safest? (49 Drugs Compared)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
49 medications are used for Medullary thyroid cancer, with 778 combined adverse event reports. The most reported drugs for Medullary thyroid cancer are VANDETANIB and CABOZANTINIB S-MALATE.
778
Total Reports
49
Drugs Used
All Medications for Medullary thyroid cancer Ranked by Safety Reports
| Drug | Brand | Reports | Deaths (all) | Hosp. (all) | Death Rate |
|---|---|---|---|---|---|
| VANDETANIB | CAPRELSA | 221 | 93 | 363 | 8.0% |
| CABOZANTINIB S-MALATE | CABOMETYX | 165 | 4,203 | 6,193 | 10.7% |
| SELPERCATINIB | RETEVMO | 116 | 160 | 342 | 14.8% |
| CABOZANTINIB | - | 73 | 767 | 2,771 | 20.0% |
| PRALSETINIB | Gavreto | 48 | 226 | 431 | 15.9% |
| LENVATINIB | Lenvima | 34 | 4,449 | 19,975 | 13.2% |
| SORAFENIB | sorafenib | 18 | 2,489 | 3,547 | 22.8% |
| CAPRELSA | - | 14 | 3 | 14 | 9.7% |
| OCTREOTIDE | Octreotide Acetate | 14 | 5,003 | 7,779 | 21.1% |
| TARLATAMAB-DLLE | IMDELLTRA (AMG757) | 13 | 103 | 206 | 12.8% |
| SUNITINIB MALATE | Sunitinib malate | 11 | 6,028 | 5,720 | 27.9% |
| COMETRIQ | - | 10 | 35 | 29 | 23.2% |
| PAZOPANIB | Pazopanib | 7 | 5,612 | 4,347 | 26.5% |
| EVEROLIMUS | EVEROLIMUS | 6 | 8,374 | 11,211 | 21.1% |
| LEVOTHYROXINE | LEVOTHYROXINE SODIUM | 5 | 4,539 | 12,155 | 7.4% |
| SUNITINIB | - | 5 | 306 | 430 | 17.2% |